Patents Assigned to BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT - Justia Patents Search

Patents Assigned to BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT

Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders

Publication number: 20110112057

Abstract: The present invention relates to treatment regimes and combination products of 20,20,21,21,21-pentafluoro-17-hydroxy-11?-[4-(hydroxyacetyl)phenyl]-19-nor-17?-pregna-4,9-dien-3-one of the formula This invention relates in particular to sequential regimes for the treatment of gynaecological disorders in which the abovementioned progesterone antagonist is administered in a first phase, and a progestogen is administered in a second phase.

Type: Application

Filed: May 7, 2009

Publication date: May 12, 2011

Applicant: BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT

Inventors: Ulrike Fuhrmann, Wolfgang Schwede, Carsten Möller